Blog

Blog - Most recent

Collaboration with Modern Biosciences to advance the development of novel compounds for RA

Affecting around 165 million people worldwide, rheumatoid arthritis (RA) is a chronic, immune
Full article

Networked Innovation

By Louise Jopling

Our Chief Scientific Officer Paul Stoffels notes that “Catalyzing innovation at Johnson & Johnson is
Full article

JJDC participates in launch of Inivata – a company focused on innovative “liquid biopsy” technology aimed at transforming cancer treatment.

Technological advances with the potential to support more informed clinical decisions are vitally
Full article

Three Of Our Collaborating Companies Make Fierce Biotech’s 2014 Fierce 15 List

Today, Fierce Biotech published its 2014 Fierce 15 list, the 12 th annual review of the top 15
Full article

The Potential Power of Better Insulin-Producing Cells for Type 1 Diabetes Treatment

Today, a study published in Nature Biotechnology outlined a “recipe” for creation of insulin
Full article

Biocartis Raises €64.5 Million

New technologies in the form of sophisticated molecular diagnostic tools are needed to advance the
Full article

Janssen Affiliate Cilag GmbH International Acquires Covagen AG

Today, Cilag GmbH International, an affiliate of Janssen Pharmaceutical Companies of Johnson &
Full article

Johnson & Johnson Innovation Forms Collaboration with Crowdfunding Platform CircleUp to Identify Transformative Consumer Companies

By Ben Wiegand , Vice President, Consumer R&D; Strategy We are excited to announce a new
Full article

Can We Teach Old Compounds New Tricks?

Different diseases can share a biological pathway and that is why studying compounds initially
Full article

Making Strides Against Alzheimer’s Disease through TargetAD Collaboration with Evotec

By Guy Seabrook

Alzheimer’s Disease may be the single biggest public health challenge facing our nation in the years
Full article

Early-Stage Life Sciences Companies in New York and Seattle Get Support Through New Collaboration with Accelerator Corporation

Developing strong syndicates to support early-stage, innovative companies is an important part of
Full article

New Immuno-Oncology Lung Cancer Collaboration Launched with Dana-Farber’s Belfer Institute; One of Seven New Strategic Oncology Partnerships

By Peter Lebowitz, Janssen Global Therapeutic Area Head, Oncology Today we announced a three-year
Full article

Accelerating Progress on Dementia Research

By Declan Jones

Alzheimer’s disease is a looming global epidemic impacting millions of people and their families
Full article

Rodin Secures $12.9 Million Series A Financing to Advance Epigenetic Modulators for CNS Disorders

We are excited for our portfolio company Rodin Therapeutics , which is advancing its epigenetic
Full article

Ken Drazan on Joining Johnson & Johnson Innovation, California

In retrospect, my early career as a liver transplant physician was excellent training for entering
Full article